Xcout Intel
Remepy
Remepy is a biotechnology research company headquartered in New York, NY, that pioneers hybrid drugs combining traditional pharmaceutical medications with targeted digital therapeutics.
Subscribe to see Remepy’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Remepy at a glance
Remepy is a biotech company headquartered in New York, United States, founded in 2022. It has raised at least $46M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $36M in August 2026. Xcout tracks 17 named people at Remepy, including Michal Tsur (CEO).
Remepy leadership
- Michal TsurCEO
- Nora SipermanChief Financial Officer
- Eran EtamChief Technology Officer
- Renan GutmanChief Product Officer
- Dr. Nira SaportaChief Therapeutics Officer
- Lisa BennettChief Marketing Officer
11 more named people on record for Remepy, with roles, board committees and tenure — see the full roster →
Remepy funding rounds
At least $46M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $36M | 12 named | |
| Seed | $10M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Remepy news
Investors
Remepy competitors
A few of Remepy's closest competitors — see the full list of competitors and alternatives →
RonanRx Inc. is a health tech startup backed by Y Combinator based in San Francisco, helping patients personalize GLP-1 treatments like Ozempic and peptides.
Essara Health builds digitally enhanced pharmaceuticals, medical-grade wearables, and licensed software-as-a-medical-device (SaMD) personalized patient experiences. The healthcare technology company is headquartered in Ernakulam, Kerala, India.
Remedy Plan, Inc. is a Maryland-based biotechnology holding company founded in 2011 that focuses on drug pipelines, patents, and clinical trials.
AtaiBeckley Inc. has its corporate headquarters located in New York, USA. The biopharmaceutical company is on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments.
Get Remepy's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Remepy in Xcout Intel
- 17 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access